Stay updated on IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.

Latest updates to the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference5%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check69 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check76 days agoChange DetectedThe study description has been updated to remove specific details about the patient population, changing from previously treated RAS-mutant tumors to a more general focus on advanced or metastatic solid tumors. Additionally, the date has been updated from February 19, 2025, to April 22, 2025.SummaryDifference1%
Stay in the know with updates to IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.